FDA Inspection
NEOLPHARMA, INC.NEOLPHARMA, INC. – FDA Inspection, Apr 1, 2022
Record Details
This FDA Inspection record concerns NEOLPHARMA, INC., with an inspection on April 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- NEOLPHARMA, INC.
- Inspection Date
- April 1, 2022
- Product Type
- Drugs
View Company Profile
ID · 333f1bda-c222-419f-af7c-dea739c8f225
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1166181
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NEOLPHARMA, INC.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 10, 2026 | Not classified | San Juan District Office | Drug Quality Assurance |
| February 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NEOLPHARMA, INC.
- FDA Inspection 1304150 - 2026-03-10
- FDA Inspection 1078192 - 2019-02-05
- FDA Inspection 1018694 - 2017-06-07
- FDA Inspection 929761 - 2015-06-18
- FDA Inspection 822275 - 2013-03-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.